TSCAN THERAPEUTICS, INC. Accounts Payable
TSCAN THERAPEUTICS, INC. (TCRX) had Accounts Payable of $3.12 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-12
- 2026-06-30: Accounts Payable, Current $3.12M.
- 2026-03-31: Accounts Payable, Current $2.30M.
- 2025-12-31: Accounts Payable, Current $1.24M.
- 2025-09-30: Accounts Payable, Current $6.35M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $3.12M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $2.30M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.24M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $6.35M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $4.54M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $4.97M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $4.28M 10-K · filed 2026-03-04 |
| 2024-09-30 | $3.65M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $3.11M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $2.12M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $2.37M 10-K · filed 2025-03-05 |
| 2023-09-30 | $3.20M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $3.39M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.77M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $2.91M 10-K · filed 2024-03-06 |
| 2022-09-30 | $2.71M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.10M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.89M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $1.76M 10-K · filed 2023-03-08 |
| 2021-09-30 | $5.07M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $3.55M 10-Q · filed 2021-08-19 |
| 2020-12-31 | $2.91M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |